Persistent Pulmonary Hypertension of the Newborn Is Associated with Mode of Delivery and Not with Maternal Use of Selective Serotonin Reuptake Inhibitors

 

 Buy Article Permissions and Reprints

ABSTRACT

We sought to determine if maternal use of selective serotonin reuptake inhibitors (SSRIs) in the second half of pregnancy is associated with persistent pulmonary hypertension of the newborn (PPHN). We performed a case-controlled study (1:6 ratio) of infants delivered at Madigan Army Medical Center with primary PPHN from 2003 through 2009. Study and control patients were compared for the following clinical factors: SSRI use after 20 weeks gestation, mode of delivery, maternal disease, body mass index, tobacco use, fetal gender, maternal age, and parity. We identified 20 cases of primary PPHN out of 11,923 births for an incidence of 0.17%. Mode of delivery was the only factor we found to be associated with PPHN. Specifically, cesarean delivery (CD) prior to the onset of labor increased the risk for PPHN: odds ratio (OR) = 4.9, confidence interval (CI) 1.7 to 14.0. Importantly, use of SSRIs in the second half of pregnancy was identified in 5% of the controls but none of the cases (OR = 0, CI 0 to 3). PPHN is associated with CD prior to the onset of labor but not with SSRI use in the second half of pregnancy. Previous studies linking PPHN to SSRI use relied on after-the-fact patient interviews and incomplete records. Additional studies are needed to verify these results.

REFERENCES

• 1 Fox W W, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management.  J Pediatr. 1983;  103 505-514
  PubMedGoogle Scholar
• 2 Ballard R A, Hansen T N, Corbet A. Respiratory failure in the term infant. In: Taeusch HW, Ballard RA, Gleason CA, eds. Avery's Diseases of the Newborn. 8th ed. Philadelphia: Elsevier; 2005: 705-714
  Google Scholar
• 3 Dakshinamurti S. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn.  Pediatr Pulmonol. 2005;  39 492-503
  CrossrefPubMedGoogle Scholar
• 4 Reece E A, Moya F, Yazigi R, Holford T, Duncan C, Ehrenkranz R A. Persistent pulmonary hypertension: assessment of perinatal risk factors.  Obstet Gynecol. 1987;  70 696-700
  PubMedGoogle Scholar
• 5 Van Marter L J, Leviton A, Allred E N et al.. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy.  Pediatrics. 1996;  97 658-663
  PubMedGoogle Scholar
• 6 Chambers C D, Hernandez-Diaz S, Van Marter L J et al.. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.  N Engl J Med. 2006;  354 579-587
  CrossrefPubMedGoogle Scholar
• 7 Källén B, Olausson P O. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn.  Pharmacoepidemiol Drug Saf. 2008;  17 801-806
  CrossrefPubMedGoogle Scholar
• 8 Cooper W O, Willy M E, Pont S J, Ray W A. Increasing use of antidepressants in pregnancy.  Am J Obstet Gynecol. 2007;  196 544. e1-5
  PubMedGoogle Scholar
• 9 Schulz K F, Grimes D A. Bias and causal associations in observational research. In: The Lancet Handbook of Essential Concepts in Clinical Research Philadelphia: Elsevier; 2006: 29-43
  Google Scholar
• 10 American College of Obstetricians and Gynecologists . ACOG Practice Bulletin No. 87 November 2007: Use of psychiatric medications during pregnancy and lactation.  Obstet Gynecol. 2007;  110 1179-1198
  CrossrefPubMedGoogle Scholar
• 11 Wichman C L, Moore K M, Lang T R, St Sauver J L, Heise Jr R H, Watson W J. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy.  Mayo Clin Proc. 2009;  84 23-27
  CrossrefPubMedGoogle Scholar
• 12 Andrade S E, McPhillips H, Loren D et al.. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.  Pharmacoepidemiol Drug Saf. 2009;  18 246-252
  CrossrefPubMedGoogle Scholar
• 13 Leder M E, Hirschfeld S, Fanaroff A. Persistent fetal circulation: an epidemiologic study.  Pediatr Res. 1980;  14 490
  PubMedGoogle Scholar
• 14 Heritage C K, Cunningham M D. Association of elective repeat cesarean delivery and persistent pulmonary hypertension of the newborn.  Am J Obstet Gynecol. 1985;  152 (6 Pt 1) 627-629
  PubMedGoogle Scholar
• 15 Keszler M, Carbone M T, Cox C, Schumacher R E. Severe respiratory failure after elective repeat cesarean delivery: a potentially preventable condition leading to extracorporeal membrane oxygenation.  Pediatrics. 1992;  89 (4 Pt 1) 670-672
  PubMedGoogle Scholar
• 16 Reece E A, Moya F, Yazigi R, Holford T, Duncan C, Ehrenkranz R A. Persistent pulmonary hypertension: assessment of perinatal risk factors.  Obstet Gynecol. 1987;  70 696-700
  PubMedGoogle Scholar
• 17 Hernández-Díaz S, Van Marter L J, Werler M M, Louik C, Mitchell A A. Risk factors for persistent pulmonary hypertension of the newborn.  Pediatrics. 2007;  120 e272-e282
  CrossrefPubMedGoogle Scholar
• 18 Levine E M, Ghai V, Barton J J, Strom C M. Mode of delivery and risk of respiratory diseases in newborns.  Obstet Gynecol. 2001;  97 439-442
  CrossrefPubMedGoogle Scholar
• 19 Hildingsson I, Rådestad I, Rubertsson C, Waldenström U. Few women wish to be delivered by caesarean section.  BJOG. 2002;  109 618-623
  PubMedGoogle Scholar
• 20 Wiklund I, Edman G, Andolf E. Cesarean section on maternal request: reasons for the request, self-estimated health, expectations, experience of birth and signs of depression among first-time mothers.  Acta Obstet Gynecol Scand. 2007;  86 451-456
  CrossrefPubMedGoogle Scholar
• 21 Milner A D, Saunders R A, Hopkin I E. Effects of delivery by caesarean section on lung mechanics and lung volume in the human neonate.  Arch Dis Child. 1978;  53 545-548
  CrossrefPubMedGoogle Scholar
• 22 Jacobstein M D, Hirschfeld S S, Flinn C, Riggs T, Fanaroff A. Neonatal circulatory changes following elective cesarean section: an echocardiographic study.  Pediatrics. 1982;  69 374-376
  PubMedGoogle Scholar
• 23 Callen P, Goldsworthy S, Graves L, Harvey D, Mellows H, Parkinson C. Mode of delivery and the lecithin/sphingomyelin ratio.  Br J Obstet Gynaecol. 1979;  86 965-968
  PubMedGoogle Scholar
• 24 Csaba I F, Sulyok E, Ertl T. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome.  J Pediatr. 1978;  92 484
  PubMedGoogle Scholar
• 25 Sulyok E, Csaba I F. Elective repeat cesarean delivery and persistent pulmonary hypertension of the newborn.  Am J Obstet Gynecol. 1986;  155 687-688
  PubMedGoogle Scholar
• 26 Bibby J G, Brunt J D, Hodgson H, Mitchell M D, Anderson A BM, Turnbull A C. Prostaglandins in umbilical plasma at elective caesarean section.  Br J Obstet Gynaecol. 1979;  86 282-284
  PubMedGoogle Scholar
• 27 Faxelius G, Hägnevik K, Lagercrantz H, Lundell B, Irestedt L. Catecholamine surge and lung function after delivery.  Arch Dis Child. 1983;  58 262-266
  CrossrefPubMedGoogle Scholar
• 28 Soifer S J, Morin III F C, Heymann M A. Prostaglandin D2 reverses induced pulmonary hypertension in the newborn lamb.  J Pediatr. 1982;  100 458-463
  PubMedGoogle Scholar

Craig ZeligM.D. 

Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Division, Madigan Army Medical Center

9040A Fitzsimmons Avenue, Tacoma, WA 98431-1100

Email: craig.zelig@us.army.mil